At the same time, 90% of U.S. prescriptions are either generics or biosimilars saving the U.S. healthcare system $445 billion in 2023 alone. Despite these achievements, there are important reforms ...

As of today, biosimilars are approved under certain guidelines ... Thakur is the co-author of ‘The Truth Pill: The Myth of Drug Regulation in India’ (2022). Prashant Reddy T.

It doesn’t come in a biosimilar version. A biosimilar medication is a drug that’s similar to a brand-name biologic drug (the reference drug). Also, biosimilars tend to cost less than brand ...

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for treating adults and children with diabetes.